DE69329293D1 - Molekülmarkierung mit 2-hydrazinopyridinderivate - Google Patents

Molekülmarkierung mit 2-hydrazinopyridinderivate

Info

Publication number
DE69329293D1
DE69329293D1 DE69329293T DE69329293T DE69329293D1 DE 69329293 D1 DE69329293 D1 DE 69329293D1 DE 69329293 T DE69329293 T DE 69329293T DE 69329293 T DE69329293 T DE 69329293T DE 69329293 D1 DE69329293 D1 DE 69329293D1
Authority
DE
Germany
Prior art keywords
pct
compound
date
sec
moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69329293T
Other languages
English (en)
Other versions
DE69329293T2 (de
Inventor
Jeffrey Abrams
James Bridger
Aaron Schwartz
Sreenivasan Padmanabhan
Evert Ultee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anormed Inc
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Application granted granted Critical
Publication of DE69329293D1 publication Critical patent/DE69329293D1/de
Publication of DE69329293T2 publication Critical patent/DE69329293T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Adhesives Or Adhesive Processes (AREA)
DE69329293T 1992-11-05 1993-11-03 Molekülmarkierung mit 2-hydrazinopyridinderivate Expired - Lifetime DE69329293T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929223168A GB9223168D0 (en) 1992-11-05 1992-11-05 Improvements in molecule labelling
PCT/GB1993/002259 WO1994010149A1 (en) 1992-11-05 1993-11-03 Molecule labelling using 2-hydraninopyridine derivatives

Publications (2)

Publication Number Publication Date
DE69329293D1 true DE69329293D1 (de) 2000-09-28
DE69329293T2 DE69329293T2 (de) 2000-12-28

Family

ID=10724568

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329293T Expired - Lifetime DE69329293T2 (de) 1992-11-05 1993-11-03 Molekülmarkierung mit 2-hydrazinopyridinderivate

Country Status (19)

Country Link
US (1) US5679778A (de)
EP (1) EP0667859B1 (de)
JP (1) JP3542597B2 (de)
KR (1) KR100295545B1 (de)
AT (1) ATE195730T1 (de)
AU (1) AU676863B2 (de)
CA (1) CA2148595C (de)
DE (1) DE69329293T2 (de)
DK (1) DK0667859T3 (de)
ES (1) ES2150950T3 (de)
FI (1) FI113044B (de)
GB (1) GB9223168D0 (de)
GR (1) GR3034883T3 (de)
HK (1) HK1013420A1 (de)
HU (1) HU226459B1 (de)
NO (1) NO305364B1 (de)
NZ (1) NZ257376A (de)
PT (1) PT667859E (de)
WO (1) WO1994010149A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
US5919934A (en) * 1997-02-19 1999-07-06 The George Washington University Compounds, compositions, and methods for cancer imaging and therapy
TW541184B (en) 1997-04-30 2003-07-11 Univ Leland Stanford Junior Use of annexin for imaging cell death in vivo
US6403054B1 (en) * 1997-05-28 2002-06-11 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US6844333B1 (en) * 1999-03-26 2005-01-18 The Trustees Of The University Of Pennsylvania Method of treating atherosclerosis
CA2723664A1 (en) * 2000-03-22 2001-09-27 Solulink, Incorporated Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
US7102024B1 (en) 2000-08-01 2006-09-05 Schwartz David A Functional biopolymer modification reagents and uses thereof
US6686461B1 (en) * 2000-03-22 2004-02-03 Solulink Bioscience, Inc. Triphosphate oligonucleotide modification reagents and uses thereof
WO2002080754A2 (en) 2001-04-03 2002-10-17 Theseus Imaging Corporation Methods for using annexin for detecting cell death in vivo and treating associated conditions
JP2004529922A (ja) 2001-04-03 2004-09-30 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 生体内における細胞死の画像化の方法
GB0130845D0 (en) * 2001-12-22 2002-02-06 James Peter Analysis
US7158353B2 (en) * 2003-11-06 2007-01-02 Seagate Technology Llc Magnetoresistive sensor having specular sidewall layers
EP1807092B1 (de) 2004-11-05 2016-09-07 The Children's Hospital of Philadelphia Biologisch abbaubare verbindungsglieder für molekulare therapien
EP2942351B1 (de) * 2011-01-31 2016-10-12 ETH Zurich Trifunktionelle vernetzungsmittel
CA2838158C (en) 2011-06-03 2019-07-16 3M Innovative Properties Company Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
EP3153180A1 (de) 2011-06-03 2017-04-12 3M Innovative Properties Company Heterobifunktionale binder mit polyethylenglykolsegmenten und daraus hergestellte immunantwort-modifizierende konjugate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
IL93432A (en) * 1989-02-24 1994-02-27 Johnson Mathey Inc Hydrazines and hydrazides, their conjugates with macromolecules, and such conjugates labeled with metallic ions
US5112953A (en) * 1989-12-29 1992-05-12 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use

Also Published As

Publication number Publication date
FI952141A0 (fi) 1995-05-04
HU226459B1 (en) 2008-12-29
WO1994010149A1 (en) 1994-05-11
DE69329293T2 (de) 2000-12-28
HUT72332A (en) 1996-04-29
AU676863B2 (en) 1997-03-27
CA2148595C (en) 2002-05-21
NO951751L (no) 1995-06-12
EP0667859B1 (de) 2000-08-23
JP3542597B2 (ja) 2004-07-14
EP0667859A1 (de) 1995-08-23
JPH08502744A (ja) 1996-03-26
ATE195730T1 (de) 2000-09-15
NO305364B1 (no) 1999-05-18
HK1013420A1 (en) 1999-08-27
AU5375594A (en) 1994-05-24
PT667859E (pt) 2001-02-28
KR100295545B1 (ko) 2001-09-17
KR950704256A (ko) 1995-11-17
DK0667859T3 (da) 2000-10-16
CA2148595A1 (en) 1994-05-11
US5679778A (en) 1997-10-21
FI952141A (fi) 1995-05-04
GR3034883T3 (en) 2001-02-28
NO951751D0 (no) 1995-05-04
FI113044B (fi) 2004-02-27
GB9223168D0 (en) 1992-12-16
NZ257376A (en) 1996-02-27
ES2150950T3 (es) 2000-12-16

Similar Documents

Publication Publication Date Title
DE69329293D1 (de) Molekülmarkierung mit 2-hydrazinopyridinderivate
NO20003133D0 (no) Anilidderivater, fremstilling og anvendelse derav
KR850003402A (ko) 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법
ATE294592T1 (de) Thioether enthaltende konjugate
RU2005110412A (ru) Производные гидроксиалкилкрахмала
KR840001174A (ko) 카르바 페넴 화합물의 제조방법
ATE416186T1 (de) Phenylethylenamin-derivate
KR960701018A (ko) 제초성의 헤테로사이클릭-치환된 피리딘(Herbicidal heterocyclic-substituted pyridines)
DE68923274D1 (de) Verfahren zur herstellung eines mit metall-radionuklid-markierten proteins.
CA2176935A1 (fr) Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d
KR850001184A (ko) 1,5-벤조티아제핀 유도체의 제조방법
KR830010072A (ko) 아미디노 피페리딘 유도체의 제조방법
KR910016695A (ko) 4-(아미노메틸) 피페리딘 유도체, 그의 제조방법 및 치료에의 이용
ES2104682T3 (es) Fluor-compuestos.
DE50004382D1 (de) Verfahren zur Herstellung von Guanidinderivaten
BR9610804A (pt) Processo para preparar um composto composto e sal dissódico
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
DE3770913D1 (de) Cinnamylamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK0429751T3 (da) Substituerede 3-aminosydnoniminer, fremgangsmåde til deres fremstilling og deres anvendelse
DK0625972T3 (da) Fremgangsmåde til fremstilling af 2-amino-7-nitrobenzothiazoler
TH16053A (de)
KR940014350A (ko) 신규 1, 6-디아미노 피리미딘-4-티온 유도체 및 이의 제조방법
KR930021636A (ko) 2,4-디하이드로-3h-1,2,4-트리아졸-3-온 유도체의 제조방법
KR970042499A (ko) 4-(N-t-부톡시카르보닐)아미노메틸-1-(N-t-부톡시카르보닐)피롤리딘-3-올의 제조방법
KR950008520A (ko) 세팔로스포린 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition